Figure 1 (Nuvaring 01)
Nuvaring Insert, Extended Release
Product Images NDC 59212-146
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Nuvaring (NDC 59212-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Nuvaring 01a)
Chemical Structure (Nuvaring 02)
Figure 3 (Nuvaring 03)
Figure 3 (Nuvaring 04)
This text appears to be describing different pregnancy rates and birth control methods. It mentions the rates of pregnancies per 100 women in a year, ranging from fewer than 1 to 85 or more. It also discusses various birth control methods such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring, and methods like avoiding sex during fertile days, spermicide, and withdrawal.*
Figure 4 (Nuvaring 05)
Figure A, Figure B, Figure C (Nuvaring 06)
Figure D, Figure E (Nuvaring 07)
Figure F (Nuvaring 08)
This text mentions medical terms related to female reproductive organs: uterus, vagina, and NuvaRing®. NuvaRing® is a contraceptive ring inserted into the vagina. It is used to prevent pregnancy by releasing hormones.*
Figure G (Nuvaring 09)
Figure H (Nuvaring 10)
Figure I (Nuvaring 11)
Figure J (Nuvaring 12)
Principle Display Panel (3 Ring Pouch Carton)
This is a description for NuvaRing, a prescription vaginal ring for contraceptive use. It contains 0.120 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol and is used for a 3-week period. Each ring contains active ingredients such as etonogestrel and ethinyl estradiol, along with excipients. The product should be stored refrigerated before dispensing and can then be stored for up to 4 months at room temperature. It is important to place an expiration date label on the product packaging when dispensing to the patient. NuvaRing is manufactured by Advanz Pharma (US) Corp and N.V. Organon in The Netherlands.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
